Advances in patient care through increasingly individualized therapy

Courtney DiNardo, Alexander E. Perl

Research output: Contribution to journalArticle

Abstract

In 2018, the acute myeloid leukaemia treatment landscape expanded notably, with several trials leading to the approval of novel targeted therapies. Furthermore, comprehensive sequencing revealed the effects of co-occurring mutations and gene expression patterns on drug sensitivity, providing hope that future treatments will be increasingly precise and personalized.

LanguageEnglish (US)
JournalNature Reviews Clinical Oncology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Patient Care
Acute Myeloid Leukemia
Therapeutics
Gene Expression
Mutation
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology

Cite this

Advances in patient care through increasingly individualized therapy. / DiNardo, Courtney; Perl, Alexander E.

In: Nature Reviews Clinical Oncology, 01.01.2019.

Research output: Contribution to journalArticle

@article{eae805e57f8042a1ad2e9dc511019769,
title = "Advances in patient care through increasingly individualized therapy",
abstract = "In 2018, the acute myeloid leukaemia treatment landscape expanded notably, with several trials leading to the approval of novel targeted therapies. Furthermore, comprehensive sequencing revealed the effects of co-occurring mutations and gene expression patterns on drug sensitivity, providing hope that future treatments will be increasingly precise and personalized.",
author = "Courtney DiNardo and Perl, {Alexander E.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1038/s41571-018-0156-2",
language = "English (US)",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Advances in patient care through increasingly individualized therapy

AU - DiNardo, Courtney

AU - Perl, Alexander E.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In 2018, the acute myeloid leukaemia treatment landscape expanded notably, with several trials leading to the approval of novel targeted therapies. Furthermore, comprehensive sequencing revealed the effects of co-occurring mutations and gene expression patterns on drug sensitivity, providing hope that future treatments will be increasingly precise and personalized.

AB - In 2018, the acute myeloid leukaemia treatment landscape expanded notably, with several trials leading to the approval of novel targeted therapies. Furthermore, comprehensive sequencing revealed the effects of co-occurring mutations and gene expression patterns on drug sensitivity, providing hope that future treatments will be increasingly precise and personalized.

UR - http://www.scopus.com/inward/record.url?scp=85059542829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059542829&partnerID=8YFLogxK

U2 - 10.1038/s41571-018-0156-2

DO - 10.1038/s41571-018-0156-2

M3 - Article

JO - Nature Reviews Clinical Oncology

T2 - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

ER -